retatrutide triple agonist weight loss trial Breaking: New data just released. TRIUMPH-1 study results on the agonist. Eli Lilly's clinical trial on Retatrutide (triple compound). 80 weeks. Phase 3 data. The results: At 12mg Lilly's triple agonist, retatrutide, delivered
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20




























